Atropine 0.01% Eye Drops – Controlling Myopia Toronto
What is Myopia?
Myopia is a condition known when the eyeball grows elongated from front to back. This causes images to be focused in front of the retina instead of focused on the retina. Myopia is also known as nearsightedness, having good near vision but poor distance vision. People with undiagnosed myopia have vision related headaches due to excessive eyestrain from trying to see objects in the distance. Atropine 0.01% eye drops – Toronto
At The Organic Compounding Pharmacy we make a treatment called Atropine 0.01% Eye Drops in our sterile compounding facility. Our sterile facility is NAPRA approved and is one of the leading facilities in Canada.
Clinical studies have shown Atropine 0.01% used once nightly can slow and control nearsightedness by roughly 50%. For more information, contact your optometrist. Atropine 0.01% eye drops – Toronto
If you have a prescription for Atropine Eye Drops, Contact Us!
- Saw SM, Shih-Yen EC, Koh A, et al. Interventions to retard myopia progression in children: an evidence-based update. Ophthalmology 2002;109:415-421; discussion 422-414; quiz 425-416, 443.
- Duncan G, Collison DJ. Role of the non-neuronal cholinergic system in the eye: a review. Life Sci 2003;72:2013-2019.
- Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006;113:2285-2291.
- Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology 2009;116:572-579.
- Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood Myopia: Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012;119:347-354.
- Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014;157:451-457 e451.
- Chia, Audrey et al. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2. Ophthalmology , Volume 123 , Issue 2 , 391 – 399.